Literature DB >> 6352482

Elevated blood viscosity in patients with borderline essential hypertension.

R L Letcher, S Chien, T G Pickering, J H Laragh.   

Abstract

In patients with borderline hypertension, total peripheral resistance (TPR) is either elevated or abnormally related to cardiac output. Since blood viscosity is one determinant of TPR, we compared various components of blood viscosity in 25 patients with borderline hypertension and 25 normal subjects. Under all experimental blood flow conditions examined, blood viscosity directly correlated with systolic and diastolic blood pressure (p less than 0.05 or better) and was greater in the hypertensive than in normal subjects. Venous hematocrit and plasma viscosity were higher in the hypertensive patients. These latter rheologic abnormalities accounted for the increased blood viscosity at higher shear rates. At lower shear rates, increased red cell aggregation, primarily mediated by elevated fibrinogen concentration, accounted for the higher blood viscosity in the hypertensive subjects. We conclude that even relatively small elevations in arterial pressure are associated with increased viscous resistance of blood to flow, and that the increased blood viscosity is a consequence of increased hematocrit, plasma viscosity, and red cell aggregation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6352482     DOI: 10.1161/01.hyp.5.5.757

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  20 in total

1.  Involvement of fibrinogen specific binding in erythrocyte aggregation.

Authors:  David Lominadze; William L Dean
Journal:  FEBS Lett       Date:  2002-04-24       Impact factor: 4.124

2.  Earthing (grounding) the human body reduces blood viscosity-a major factor in cardiovascular disease.

Authors:  Gaétan Chevalier; Stephen T Sinatra; James L Oschman; Richard M Delany
Journal:  J Altern Complement Med       Date:  2012-07-03       Impact factor: 2.579

3.  Prevalence of hypertension in type 1 (insulin-dependent) diabetes mellitus.

Authors:  L O Simpson
Journal:  Diabetologia       Date:  1991-01       Impact factor: 10.122

4.  Effects of indomethacin and sulindac on blood pressure of hypertensive patients.

Authors:  L O Simpson
Journal:  Br Med J (Clin Res Ed)       Date:  1986-05-24

5.  Seasonal hematocrit variation and health risks in the adult population of Kinshasa, Democratic Republic of Congo.

Authors:  C Makena Hightower; Joyce D Hightower; Beatriz Y Salazar Vázquez; Marcos Intaglietta
Journal:  Vasc Health Risk Manag       Date:  2009-11-23

6.  A genome-wide association study of red blood cell traits using the electronic medical record.

Authors:  Iftikhar J Kullo; Keyue Ding; Hayan Jouni; Carin Y Smith; Christopher G Chute
Journal:  PLoS One       Date:  2010-09-28       Impact factor: 3.240

7.  Increased ability of erythrocytes to aggregate in spontaneously hypertensive rats.

Authors:  David Lominadze; Dale A Schuschke; Irving G Joshua; William L Dean
Journal:  Clin Exp Hypertens       Date:  2002-07       Impact factor: 1.749

8.  Proteome Profiling of Vitreoretinal Diseases by Cluster Analysis.

Authors:  Tomomi Shitama; Hideyuki Hayashi; Sumiyo Noge; Eiichi Uchio; Kenji Oshima; Hisao Haniu; Nobuaki Takemori; Naoka Komori; Hiroyuki Matsumoto
Journal:  Proteomics Clin Appl       Date:  2008-09       Impact factor: 3.494

9.  Anemia lessens and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass.

Authors:  D L Garcia; S Anderson; H G Rennke; B M Brenner
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

10.  Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium.

Authors:  Santhi K Ganesh; Neil A Zakai; Frank J A van Rooij; Nicole Soranzo; Albert V Smith; Michael A Nalls; Ming-Huei Chen; Anna Kottgen; Nicole L Glazer; Abbas Dehghan; Brigitte Kuhnel; Thor Aspelund; Qiong Yang; Toshiko Tanaka; Andrew Jaffe; Joshua C M Bis; Germaine C Verwoert; Alexander Teumer; Caroline S Fox; Jack M Guralnik; Georg B Ehret; Kenneth Rice; Janine F Felix; Augusto Rendon; Gudny Eiriksdottir; Daniel Levy; Kushang V Patel; Eric Boerwinkle; Jerome I Rotter; Albert Hofman; Jennifer G Sambrook; Dena G Hernandez; Gang Zheng; Stefania Bandinelli; Andrew B Singleton; Josef Coresh; Thomas Lumley; André G Uitterlinden; Janine M Vangils; Lenore J Launer; L Adrienne Cupples; Ben A Oostra; Jaap-Jan Zwaginga; Willem H Ouwehand; Swee-Lay Thein; Christa Meisinger; Panos Deloukas; Matthias Nauck; Tim D Spector; Christian Gieger; Vilmundur Gudnason; Cornelia M van Duijn; Bruce M Psaty; Luigi Ferrucci; Aravinda Chakravarti; Andreas Greinacher; Christopher J O'Donnell; Jacqueline C M Witteman; Susan Furth; Mary Cushman; Tamara B Harris; Jing-Ping Lin
Journal:  Nat Genet       Date:  2009-10-11       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.